Cytomegalovirus viremia in HIV-infected patients treated with zidovudine (Q46071708)

19 December 2017

title

Cytomegalovirus viremia in HIV-infected patients treated with zidovudine (English)

1 reference

19 December 2017

0 references

Segondy M

1

1 reference

19 December 2017

Atoui N

2

1 reference

19 December 2017

Reynes J

3

1 reference

19 December 2017

Vendrell JP

4

1 reference

19 December 2017

Ducos J

5

1 reference

19 December 2017

Blanc P

6

1 reference

19 December 2017

Mandin J

7

1 reference

19 December 2017

publication date

1 January 1990

1 reference

19 December 2017

Scandinavian Journal of Infectious Diseases

published in

1 reference

19 December 2017

volume

22

1 reference

19 December 2017

issue

6

1 reference

19 December 2017

page(s)

653-657

1 reference

19 December 2017

Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Cytomegalovirus infections in homosexual men. An epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Human immunodeficiency virus (HIV) antigenemia (p24) in the acquired immunodeficiency syndrome (AIDS) and the effect of treatment with zidovudine (AZT).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365549009027117

10.3109/00365549009027117

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

2178278

1 reference

19 December 2017